IBD Care Reimagined: Personalized, Proactive, and Target-Driven Management
David T. Rubin, MD
Michael Dolinger, MD, MBA
Florence Odufalu, MD
Ugo Iroku, MD, MHS
Sharon Dudley-Brown, PhD, FNP-BC, FAAN, FAANP
The Future of Biologic Treatment in IBD: What’s on the Horizon
The Evolving Role of Small Molecules in IBD Care
Beyond One-Size-Fits-All: Individualizing First-Line IBD Treatment
Small Molecules in IBD: JAK Inhibitors and S1P Modulators
Targeting IL-23 Pathways: Evolving Biologic Strategies in IBD
Gut-Selective Therapy: Understanding Anti-Integrins in IBD
Putting It All Together: Challenges Addressed
IBD Masterclass: Foundations of Pathophysiology and Targeted Therapy
Understanding the Microbiome’s Role in IBD Management
IBD Beyond Symptoms: What Community GIs Need to Know
Switching Strategies: Switch or Stay—What’s Your Call?
David Rubin, MD
Brooke Hodnick, PA-C, MPAS
Treat-to-Target: Are We There Yet?
Kimberly D. Orleck, PA-C
Jennifer Geremia, PA-C
From Flare to Farewell: The IBD Care Playbook for Advanced Practice Providers
Pathogenesis of IBD
Michele Rubin, BSN, MSN, APRN-CNS, CGRN
Surgical Management of Inflammatory Bowel Disease
Loading...
We're glad to see you're enjoying Crohn's Colitis Professional… but how about a more personalized experience?
Press cancel to remain on Crohn's Colitis Professional. Press the link below or the continue button to keep going.